Tirzepatide, a innovative medication, is sparking considerable excitement within the scientific community. It functions differently from traditional diabetes medications, targeting both receptors involved in sugar regulation and appetite . Initial trials have demonstrated significant efficacy in controlling blood sugar in individuals with adult-ons